We have the ability to get something done very quickly and at scale: Murali Neelakantan on production of COVID-19 vaccines in India

Neelakantan sheds light on what role Intellectual Property Rights play on how fast vaccines can be produced at a large scale, the gaps in India's COVID-19 vaccination policy, and more.

Almost halfway through 2021, India finds itself in the midst of a healthcare crisis effected by the proliferation of the second wave of COVID-19.

Loading content, please wait...